Objective To investigate the clinical efficacy and safety of She medical Shiliangcha compound prescription in treating obesity with syndrome of internal exuberance of phlegm-damp complicated with obstructive sleep apnea hypopnea syndrome(OSAHS).Methods A total of 90 patients with obesity with syndrome of internal exuberance of phlegm-damp complicated with OSAHS diagnosed and treated in Lishui Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University from January 2023 to February 2024 were selected and divided into control group and treatment group according to random number table method,with 45 cases in each group.Patients in control group received continuous positive airway pressure(CPAP)with non-invasive ventilator,and patients in treatment group was treated with She medical Shiliangcha compound prescription on the basis of control group.Both groups of patients were treated for 3 months.Body mass index(BMI),Epworth sleeping scale(ESS)score,sleep apnea index and adverse reactions were compared between two groups.Results After treatment,ESS score,BMI,apnea-hypopnea index(AHI)in two groups were significantly lower than before treatment,and minimum blood oxygen saturation(LSaO2)was significantly higher than before treatment(P＜0.05).ESS score,BMI and AHI in treatment group were significantly lower than those in control group,and LSaO2 was significantly higher than that in control group(P＜0.05).The incidence of adverse reactions in treatment group was significantly lower than that in control group(x2=6.429,P=0.011).Conclusion The She medical Shiliangcha compound prescription has a definite therapeutic effect on the treatment of obesity with syndrome of internal exuberance of phlegm-damp complicated with OSAHS.It can reduce BMI and ESS score,improve sleep apnea parameters,and reduce adverse reactions caused by non-invasive ventilator assisted ventilation.

Objective To investigate the clinical efficacy and safety of She medical Shiliangcha compound prescription in treating obesity with syndrome of internal exuberance of phlegm-damp complicated with obstructive sleep apnea hypopnea syndrome(OSAHS).Methods A total of 90 patients with obesity with syndrome of internal exuberance of phlegm-damp complicated with OSAHS diagnosed and treated in Lishui Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University from January 2023 to February 2024 were selected and divided into control group and treatment group according to random number table method,with 45 cases in each group.Patients in control group received continuous positive airway pressure(CPAP)with non-invasive ventilator,and patients in treatment group was treated with She medical Shiliangcha compound prescription on the basis of control group.Both groups of patients were treated for 3 months.Body mass index(BMI),Epworth sleeping scale(ESS)score,sleep apnea index and adverse reactions were compared between two groups.Results After treatment,ESS score,BMI,apnea-hypopnea index(AHI)in two groups were significantly lower than before treatment,and minimum blood oxygen saturation(LSaO2)was significantly higher than before treatment(P＜0.05).ESS score,BMI and AHI in treatment group were significantly lower than those in control group,and LSaO2 was significantly higher than that in control group(P＜0.05).The incidence of adverse reactions in treatment group was significantly lower than that in control group(x2=6.429,P=0.011).Conclusion The She medical Shiliangcha compound prescription has a definite therapeutic effect on the treatment of obesity with syndrome of internal exuberance of phlegm-damp complicated with OSAHS.It can reduce BMI and ESS score,improve sleep apnea parameters,and reduce adverse reactions caused by non-invasive ventilator assisted ventilation.

Objective To explore drug use patterns in treatment of lung cancer based on traditional Chinese medicine inheritance assistance platform.Methods A total of 200 effective prescriptions for the treatment of lung cancer patients in the outpatient department of Lishui Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University from January 2022 to September 2023 were collected and input into the traditional Chinese medicine inheritance assistance platform to conduct association rules and cluster analysis of drugs.Results A total of 200 effective prescriptions were included,involving 146 traditional Chinese medicines.The medicinal properties were mainly cold,warm and flat,and the medicinal flavours were mainly sweet,bitter and pungent,which mainly belong to lung,spleen,stomach and heart meridian.The most frequently used Chinese medicines were Radix Codonopsis Lanceolatae,Radix et Rhizoma Glycyrrhizae,Radix et Rhizoma Salviae Miltiorrhizae,Rhizoma Pinelliae,Actinidia valvata Dunn,Fritillariae Thunbergii Bulbus,etc.27 groups of core drug combinations were obtained,and 5 new prescriptions were obtained.Conclusion Clinical diagnosis and treatment of lung cancer is closely related to the core pathogenesis of Yin deficiency and stasis toxicity,and at the same time,it takes care of the acquired spleen and stomach,mind-body harmony,reflecting the academic thought of traditional Chinese medicine tumor,which reinforce healthy qi to anti-cancer and the holistic view of traditional Chinese medicine.